# FDA Inspection 1080593 - Tongling Jieya Biologic Technology Stock Co., Ltd. - December 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/tongling-jieya-biologic-technology-stock-co-ltd/62d9cebf-e5c5-4dd8-a80a-f348461ac5b3
Source feed: FDA_Inspections

> FDA Inspection 1080593 for Tongling Jieya Biologic Technology Stock Co., Ltd. on December 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080593
- Company Name: Tongling Jieya Biologic Technology Stock Co., Ltd.
- Inspection Date: 2018-12-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266873 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/tongling-jieya-biologic-technology-stock-co-ltd/0e44c4e9-0d8b-490d-9b4b-993c940807a4)
- [FDA Inspection 1266873 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/tongling-jieya-biologic-technology-stock-co-ltd/69452308-a894-44f7-8863-4a54d7094001)
- [FDA Inspection 995169 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/tongling-jieya-biologic-technology-stock-co-ltd/c2f7d51a-cfd3-4cd3-b72e-97c162d1dac5)

Company: https://www.keypedia.com/companies/tongling-jieya-biologic-technology-stock-co-ltd/ed48c60a-b7c4-4ded-9bd4-38457df01a87

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
